Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 points on Wednesday.
Shares of Coherus BioSciences, Inc. (NASDAQ:CHRS) shares rose sharply in pre-market trading following the company's announcement of the U.S. Food and Drug Administration's (FDA) approval of UDENYCA ONBODY for pegfilgrastim-cbqv.
UDENYCA ONBODY is the company's on-body injector presentation of UDENYCA (pegfilgrastim-cbqv), a pegfilgrastim biosimilar administered the day after chemotherapy to reduce the incidence of infection as manifested by febrile neutropenia.
Coherus BioSciences shares jumped 34.8% to $2.94 in pre-market trading.
Here are some big stocks recording gains in today’s pre-market trading session.
Now Read This: Investor Sentiment Improves; Dow Jumps Over 150 Points
Don’t forget to check out our premarket coverage here